BrightGene Bio-Medical Technology Co Ltd
SSE:688166
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Price:
46.49
CNY
1.88%
Market Closed
Market Cap:
¥19.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
|
CN |
|
S
|
SS&C Technologies Holdings Inc
XBER:WGSA
|
US |
Balance Sheet
Balance Sheet Decomposition
BrightGene Bio-Medical Technology Co Ltd
BrightGene Bio-Medical Technology Co Ltd
Balance Sheet Decomposition is not available for
BrightGene Bio-Medical Technology Co Ltd
BrightGene Bio-Medical Technology Co Ltd
Balance Sheet
BrightGene Bio-Medical Technology Co Ltd
BrightGene Bio-Medical Technology Co Ltd
Currency: CNY
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
42
|
103
|
206
|
553
|
340
|
333
|
1 152
|
971
|
754
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
333
|
1 152
|
971
|
754
|
|
| Cash Equivalents |
42
|
103
|
206
|
553
|
339
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
1
|
0
|
90
|
150
|
180
|
1
|
50
|
51
|
0
|
|
| Total Receivables |
82
|
90
|
149
|
199
|
185
|
412
|
372
|
382
|
400
|
|
| Accounts Receivables |
76
|
75
|
133
|
185
|
177
|
373
|
303
|
283
|
328
|
|
| Other Receivables |
6
|
14
|
16
|
14
|
8
|
38
|
69
|
99
|
73
|
|
| Inventory |
63
|
86
|
103
|
137
|
203
|
200
|
280
|
345
|
365
|
|
| Other Current Assets |
21
|
21
|
14
|
23
|
38
|
47
|
84
|
92
|
121
|
|
| Total Current Assets |
209
|
300
|
563
|
1 062
|
946
|
993
|
1 938
|
1 840
|
1 640
|
|
| PP&E Net |
136
|
190
|
225
|
264
|
603
|
1 490
|
2 180
|
2 527
|
2 722
|
|
| PP&E Gross |
136
|
190
|
225
|
264
|
603
|
1 490
|
2 180
|
2 527
|
2 722
|
|
| Accumulated Depreciation |
54
|
67
|
75
|
98
|
125
|
162
|
193
|
260
|
357
|
|
| Intangible Assets |
8
|
8
|
50
|
50
|
49
|
81
|
82
|
94
|
104
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
3
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Long-Term Investments |
0
|
0
|
10
|
8
|
157
|
348
|
399
|
488
|
497
|
|
| Other Long-Term Assets |
31
|
27
|
28
|
37
|
73
|
50
|
54
|
76
|
197
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
3
|
|
| Total Assets |
384
N/A
|
525
+37%
|
875
+67%
|
1 421
+62%
|
1 828
+29%
|
2 970
+62%
|
4 661
+57%
|
5 032
+8%
|
5 164
+3%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
31
|
29
|
40
|
41
|
80
|
208
|
252
|
228
|
266
|
|
| Accrued Liabilities |
9
|
14
|
19
|
27
|
35
|
61
|
72
|
73
|
77
|
|
| Short-Term Debt |
78
|
1
|
0
|
12
|
140
|
261
|
125
|
157
|
116
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
26
|
315
|
414
|
537
|
|
| Other Current Liabilities |
46
|
34
|
46
|
28
|
35
|
26
|
48
|
50
|
57
|
|
| Total Current Liabilities |
164
|
79
|
106
|
108
|
292
|
583
|
812
|
922
|
1 052
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
78
|
619
|
1 608
|
1 636
|
1 590
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
1
|
63
|
50
|
49
|
43
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
26
|
26
|
26
|
56
|
85
|
|
| Total Liabilities |
164
N/A
|
79
-52%
|
106
+34%
|
108
+3%
|
396
+266%
|
1 291
+226%
|
2 470
+91%
|
2 663
+8%
|
2 770
+4%
|
|
| Equity | ||||||||||
| Common Stock |
40
|
45
|
48
|
410
|
410
|
410
|
422
|
422
|
422
|
|
| Retained Earnings |
21
|
25
|
98
|
209
|
346
|
555
|
743
|
898
|
1 046
|
|
| Additional Paid In Capital |
201
|
376
|
623
|
701
|
701
|
739
|
1 008
|
1 057
|
982
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
57
|
84
|
122
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
|
| Other Equity |
0
|
0
|
1
|
7
|
25
|
26
|
75
|
75
|
75
|
|
| Total Equity |
220
N/A
|
446
+103%
|
770
+73%
|
1 313
+71%
|
1 432
+9%
|
1 678
+17%
|
2 192
+31%
|
2 369
+8%
|
2 395
+1%
|
|
| Total Liabilities & Equity |
384
N/A
|
525
+37%
|
875
+67%
|
1 421
+62%
|
1 828
+29%
|
2 970
+62%
|
4 661
+57%
|
5 032
+8%
|
5 164
+3%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
40
|
45
|
48
|
410
|
410
|
410
|
422
|
422
|
422
|
|
Switch to:
Switch to:
See Also
Discover More
